In addition, NTNG1 exhibited hypermethylation mutations in CRC patients, with the mutation frequency being highest at the EGF‐like 3 locations in the NTNG1 laminin EGF domains.67 This evidence concerns the gene LAMB2 and colorectal carcinoma.